Antinuclear antibodies in children: clinical signification and diagnosis utility
##plugins.themes.academic_pro.article.main##
Abstract
Background: Antinuclear antibodies (ANA) test is used to screen adults as well as children for connective tissue diseases (CTD) and autoimmune hepatitis. However, interpretation of ANA positivity can be delicate.
Aim: to determine clinical significance and diagnosis utility of ANA positivity in children. Methods: Patients from a general pediatric department with ANA positive results were included (follow-up period of 2 years). ANA screening was performed by indirect immunofluorescence (IIF) on HEp-2 cells substrate (BioSystems®). In case of ANA positivity (cut-off: 1:80), the specificity was determined by IIF on Crithidia luciliea substrate (BioSystems®) and immunodot (Euroimmun®).
Results: Among 102 ANA tests, 55 (53,9%) were positive. We recorded the data of 38 patients (age average: 9,5 years - sex ratio: 0.72). The most frequent signs were join pain (55,3%). ANA titer varied between 1:80 (39,5% of cases) and 1:1280 (2,6% of cases). Typing was negative in 89,5% of cases. The majority (42,1%) of children with positive ANA test had musculoskeletal diseases. The others (57,9%) had systemic lupus erythematosus(n=2), overlap syndrome(n=1), rheumatoid purpura(n=2), idiopathic thrombocytopenic purpura(n=1), coeliac disease(n=1) or non-autoimmune diseases/no confirmed diagnosis(n=15).
Conclusions: ANA prevalence in children was relatively high. When the pretest probability is low, the positive predictive value for CTD or autoimmune hepatitis is low. However, depending on the clinical context, ANA detection can represent a supplement diagnostic tool for these diseases and/or can lead to a clinico-biological monitoring.
Keywords:
antinuclear antibodies; child; connective tissue diseases; autoimmune hepatitis; musculoskeletal diseases##plugins.themes.academic_pro.article.details##
References
- 1. Pasquali J, Goetz J. Que faire en présence d'anticorps antinucléaires chez l'adulte ? In: Lupus éryythémateux. 2013. p. 103. 2. Mcghee JL, Kickingbird LM, Jarvis JN. Clinical utility of antinuclear antibody tests in children. BMC Pediatr. 2004;6:1-6. 3. Peng SL, Craft JE. Anti-nuclear Antibodies. In: Kelley and Firestein's Textbook of Rheumatology (Tenth Edition). 2017. p. 817. 4. Arroyave CM, Giambrone MJ, Rich KC, Walaszek M. The frequency of antinuclear antibody (ANA) in children by use of mouse kidney (MK) and human epithelial cells (HEp-2) as substrates. J Allergy Clin Immunol. 1988;82(5 PART 1):741-4. 5. Meroni PL, Schur PH. ANA screening: an old test with new recommendations. Ann Rheum Dis. 2010;69(8):1420-2. 6. Abeles AM, Abeles M. The Clinical Utility of a Positive Antinuclear Antibody Test Result. Am J Med. 2013;126(4):342-8. 7. Wijeyesinghe U, Russell AS. Outcome of high titer antinuclear antibody positivity in individuals without connective tissue disease: A 10-year follow-up. Clin Rheumatol. 2008;27(11):1399-402. 8. Mariz HA, Sato EI, Barbosa SH, Rodrigues SH, Dellavance A, Andrade LEC. Pattern on the antinuclear antibody-HEp-2 test is a critical parameter for discriminating antinuclear antibody-positive healthy individuals and patients with autoimmune rheumatic diseases. Arthritis Rheum. 2011;63(1):191-200. 9. Wang K, Yang Y, Chuang Y, Chan P, Yu H, Lee J, et al. The initial manifestations and final diagnosis of patients with high and low titers of antinuclear antibodies after 6 months of follow-up. J Microbiol Immunol Infect. 2011;44(3):222-8. 10. Dinser R, Braun A, Jendro MC, Engel A. Increased titres of anti-nuclear antibodies do not predict the development of associated disease in the absence of initial suggestive signs and symptoms. Scand J Rheumatol. 2007;36(6):448-51. 11. Feki S, Frikha F, Hadj Y Ben, Abed S, Ayed M Ben, Turki H, et al. Prévalence et valeur diagnostique des anticorps antinucléaires de spécificité antigénique indéterminée : étude rétrospective à propos d'une série de 90 patients. La Rev Médecine Interne. 2012;33(9):475-81. 12. Pradhan V, Patwardhan M, Rajadhyaksha a, Ghosh K. Clinical and Immunological Profile of Systemic Lupus Erythematosus. Indian Pediatr. 2012;45:10-5. 13. Sener AG. Autoantibodies in autoimmune liver diseases. Acta pthologica, Microbiol imminologica Scand. 2015;123(11):915-9. 14. Mieli-vergani G, Ph D, Vergani D, Ph D. Autoimmune Hepatitis in Children : What is Different from Adult AIH ? Semin Liver Dis. 2009;29(3):297-306. 15. Vergani D, Alvarez F, Bianchi FB, Cançado ELR, MacKay IR, Manns MP, et al. Liver autoimmune serology: A consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis Group. J Hepatol. 2004;41(4):677- 83. 16. Campanilho-Marques R, Bogas M, Ramos F, Santos MJ, Fonseca JE. Prognostic value of antinuclear antibodies in juvenile idiopathic arthritis and anterior uveitis. Results from a systematic literature review. Acta Reum Port. 2014;39:116-22. 17. Sperotto F, Cuffaro G, Brachi S, Seguso M, Zulian F. Prevalence of antinuclear antibodies in schoolchildren during puberty and possible relationship with musculoskeletal pain: A longitudinal study. J Rheumatol. 2014;41(7):1405-8. 18. Somers EC, Monrad SU, Warren JS, Solano M, Schnaas L, Hernandez-Avila M, et al. Antinuclear antibody prevalence in a general pediatric cohort from Mexico City: Discordance between immunofluorescence and multiplex assays. Clin Epidemiol. 2017;9:1-8. 19. Wananukul S, Voramethkul W, Kaewopas Y, Hanvivatvong O. Prevalence of Positive Antinuclear Antibodies in Healthy Children. Asian Pacific J Allergy Immunol. 2005;23:153-7. 20. Hilário MOE, Len CA, Roja SC, Terreri MT, Almeida G, Andrade LEC. Frequency of Antinuclear Antibodies in Healthy Children and Adolescents. Clin Pediatr (Phila). 2004;637-42. 21. Pratt EL, Tarantino MD, Wagner D, Pescovitz OH, Bowyer S, Shapiro AD. Prevalence of Elevated Antithyroid Antibodies and Antinuclear Antibodies in Children With Immune Thrombocytopenic Purpura. Am J Hematol. 2005;79:175-9. 22. Segni M, Pucarelli I, Truglia S, Turriziani I, Serafinelli C, Conti F. High prevalence of antinuclear antibodies in children with thyroid autoimmunity. J Immunol Res. 2014; 23. Bigi S, Marrie R, Yeh E, Banwell B. Antinuclear antibodies in pediatric acquired demyelinating diseases of the central nervous system. Mult Scler J. 2014;20(12):1665- 6.